Page 39 - Aet News Today

Value-based care depends on keeping a total population of patients healthier and less in need of higher-cost services. To do so, organizations must be able to predict costs in advance, better understand patient risks, and manage the cost of services. Corporate healthcare is set up to do just that.

Illumina has decided against further appeals of U.S. and European antitrust litigation challenging its acquisition of liquid biopsy company Grail. Illumina expects to have terms of the divestiture set by the end of the second quarter of 2024.

Season Health has secured a $7 million investment from Inception Health and Ziegler Link-age Fund. The financing will be used to develop and scale its food-as-medicine programs, including for diabetes and high-risk pregnancies.

This bipartisan legislation will help create a more transparent process that allows patients and physicians to seek exceptions to step therapy protocol. Although it only applies to employer-sponsored health plans, the bill represents an important step towards reining in this troubling practice.

WellSpan Health launched a virtual nursing pilot involving Artisight’s smart hospital platform. So far, WellSpan’s nurses “are loving it,” said Erin Langmead, the health system’s interim director of clinical informatics and physician informatics support.

In this episode, we're joined by Marielle Farina, senior manager of Deloitte. She's here to discuss a report she recently co-authored that found that employed women pay significantly more in out-of-pocket medical costs than employed men.

To identify true growth opportunities, investors must consider how companies are using AI to revolutionize the treatment journey. Some companies are doing just that via Software as a Medical Device (SaMD), particularly by developing prescription digital therapeutics (PDTs).

To harness the best parts of AI — and avoid its worst possible outcomes — you need an AI strategy that not only includes technical implementation tactics but also prioritizes efforts to minimize bias, address ethical considerations, and build consumer trust and confidence.

WeightWatchers' new GLP-1 program offers daily nutritional and activity targets, recommended foods, recipes, food and activity tracking, a digital community, virtual workshops and access to coaches 24/7. 

The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.